Cargando…

The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity

The synergy of radiation and the immune system is currently receiving significant attention in oncology as numerous studies have shown that cancer irradiation can induce strong anti-tumor immune responses. It remains unclear, however, what are the best radiation fractionation protocols to maximize t...

Descripción completa

Detalles Bibliográficos
Autores principales: Poleszczuk, Jan, Enderling, Heiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275030/
https://www.ncbi.nlm.nih.gov/pubmed/30380596
http://dx.doi.org/10.3390/ijms19113377
_version_ 1783377745552605184
author Poleszczuk, Jan
Enderling, Heiko
author_facet Poleszczuk, Jan
Enderling, Heiko
author_sort Poleszczuk, Jan
collection PubMed
description The synergy of radiation and the immune system is currently receiving significant attention in oncology as numerous studies have shown that cancer irradiation can induce strong anti-tumor immune responses. It remains unclear, however, what are the best radiation fractionation protocols to maximize the therapeutic benefits of this synergy. Here, we present a novel mathematical model that can be used to predict and dissect the complexity of the immune-mediated response at multiple tumor sites after applying focal irradiation and systemic immunotherapy. We successfully calibrate the proposed framework with published experimental data, in which two tumors were grown in mice at two spatially-separated sites from which only one was irradiated using various radiation fractionation protocols with and without concurrent systemic immunotherapy. The proposed model is calibrated to fit the temporal dynamics of tumor volume at both sites and can predict changes in immune infiltration in the non-irradiated tumors. The model was then used to investigate additional radiation fractionation protocols. Model simulations suggest that the optimal radiation doses per fraction to maximize anti-tumor immunity are between 10 and 13 Gy, at least for the experimental setting used for model calibration. This work provides the framework for evaluating radiation fractionation protocols for radiation-induced immune-mediated systemic anti-tumor responses.
format Online
Article
Text
id pubmed-6275030
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62750302018-12-15 The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity Poleszczuk, Jan Enderling, Heiko Int J Mol Sci Article The synergy of radiation and the immune system is currently receiving significant attention in oncology as numerous studies have shown that cancer irradiation can induce strong anti-tumor immune responses. It remains unclear, however, what are the best radiation fractionation protocols to maximize the therapeutic benefits of this synergy. Here, we present a novel mathematical model that can be used to predict and dissect the complexity of the immune-mediated response at multiple tumor sites after applying focal irradiation and systemic immunotherapy. We successfully calibrate the proposed framework with published experimental data, in which two tumors were grown in mice at two spatially-separated sites from which only one was irradiated using various radiation fractionation protocols with and without concurrent systemic immunotherapy. The proposed model is calibrated to fit the temporal dynamics of tumor volume at both sites and can predict changes in immune infiltration in the non-irradiated tumors. The model was then used to investigate additional radiation fractionation protocols. Model simulations suggest that the optimal radiation doses per fraction to maximize anti-tumor immunity are between 10 and 13 Gy, at least for the experimental setting used for model calibration. This work provides the framework for evaluating radiation fractionation protocols for radiation-induced immune-mediated systemic anti-tumor responses. MDPI 2018-10-29 /pmc/articles/PMC6275030/ /pubmed/30380596 http://dx.doi.org/10.3390/ijms19113377 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Poleszczuk, Jan
Enderling, Heiko
The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity
title The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity
title_full The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity
title_fullStr The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity
title_full_unstemmed The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity
title_short The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity
title_sort optimal radiation dose to induce robust systemic anti-tumor immunity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275030/
https://www.ncbi.nlm.nih.gov/pubmed/30380596
http://dx.doi.org/10.3390/ijms19113377
work_keys_str_mv AT poleszczukjan theoptimalradiationdosetoinducerobustsystemicantitumorimmunity
AT enderlingheiko theoptimalradiationdosetoinducerobustsystemicantitumorimmunity
AT poleszczukjan optimalradiationdosetoinducerobustsystemicantitumorimmunity
AT enderlingheiko optimalradiationdosetoinducerobustsystemicantitumorimmunity